49439
document
A prospective , double-blind , randomized , controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy ( HBOT ) to standard wound care only for the treatment of chronic , non-healing ulcers of the lower limb in patients with diabetes mellitus : a study protocol . BACKGROUND It has been suggested that the use of adjunctive hyperbaric oxygen therapy improves the healing of diabetic foot ulcers , and decreases the risk of lower extremity amputations . A limited number of studies have used a double blind approach to evaluate the efficacy of hyperbaric oxygen therapy in the treatment of diabetic ulcers . The primary aim of this study is to assess the efficacy of hyperbaric oxygen therapy plus standard wound care compared with standard wound care alone in preventing the need for major amputation in patients with diabetes mellitus and chronic ulcers of the lower limb . METHODS/DESIGN One hundred and eighteen ( 59 patients per arm ) patients with non-healing diabetic ulcers of the lower limb , referred to the Judy Dan Research and Treatment Centre are being recruited if they are at least 18 years of age , have either Type 1 or 2 diabetes with a Wagner grading of foot lesions 2 , 3 or 4 on lower limb not healing for at least 4 weeks . Patients receive hyperbaric oxygen therapy every day for 6 weeks during the treatment phase and are provided ongoing wound care and weekly assessments . Patients are required to return to the study centre every week for an additional 6 weeks of follow-up for wound evaluation and management . The primary outcome is freedom from having , or meeting the criteria for , a major amputation ( below knee amputation , or metatarsal level ) up to 12 weeks after randomization . The decision to amputate is made by a vascular surgeon . Other outcomes include wound healing , effectiveness , safety , healthcare resource utilization , quality of life , and cost-effectiveness . The study will run for a total of about 3 years . DISCUSSION The results of this study will provide detailed information on the efficacy of hyperbaric oxygen therapy for the treatment of non-healing ulcers of the lower limb . This will be the first double-blind randomized controlled trial for this health technology which evaluates the efficacy of hyperbaric oxygen therapy in prevention of amputations in diabetic patients . TRIAL REGISTRATION ClinicalTrials.gov Identifier : NCT00621608 .
49440
Intervention_Physical
adjunctive hyperbaric oxygen therapy ( HBOT )
49441
Intervention_Physical
adjunctive hyperbaric oxygen therapy
49442
Intervention_Physical
hyperbaric oxygen therapy
49443
Intervention_Physical
hyperbaric oxygen therapy plus standard wound care
49444
Intervention_Physical
standard wound care
49445
Intervention_Physical
hyperbaric oxygen therapy
49446
Outcome_Physical
chronic , non-healing ulcers
49447
Outcome_Physical
diabetic foot ulcers
49448
Outcome_Physical
lower extremity amputations
49449
Outcome_Other
major amputation
49450
Outcome_Physical
freedom from having , or meeting the criteria for , a major amputation ( below knee amputation , or metatarsal level )
49451
Outcome_Physical
wound healing
49452
Outcome_Other
effectiveness
49453
Outcome_Other
safety
49454
Outcome_Other
healthcare resource utilization
49455
Outcome_Mental
quality of life
49456
Outcome_Physical
cost-effectiveness
49457
Outcome_Adverse-effects
amputations
49458
Participant_Condition
chronic , non-healing ulcers of the lower limb
49459
Participant_Condition
diabetes mellitus
49460
Participant_Condition
chronic ulcers
49461
Participant_Sample-size
One hundred and eighteen
49462
Participant_Sample-size
59
49463
Participant_Condition
non-healing diabetic ulcers of the lower limb
49464
Participant_Age
18 years of age
49465
Participant_Condition
Type 1 or 2 diabetes
49466
Participant_Condition
Wagner grading of foot lesions 2 , 3 or 4 on lower limb not healing for at least 4 weeks